CTP Newsroom
Stay up to date on the latest news and events from FDA's Center for Tobacco Products through the CTP Newsroom.
From press releases to public meetings to email newsletters, stay up to date on the latest news and events from the FDA Center for Tobacco Products.
Latest News
FDA Puts Firms Responsible for Esco Bars and Breeze — Two Popular Disposable E-cigarette Brands— on Notice
Actions are agency’s latest to address flavored, disposable e-cigarettes that appeal to youth.
May 25, 2023
FDA Denies Marketing of 250+ Flavored and Tobacco-Flavored E-Liquids
Multidisciplinary Scientific Review Finds Products Do Not Meet the Necessary Public Health Standard.
May 18, 2023
FDA Issues Marketing Denial Orders for Approximately 6,500 Flavored E-cigarette Products
Products Cannot Be Sold or Risk Enforcement
May 12, 2023
2023
May
- FDA Puts Firms Responsible for Esco Bars and Breeze — Two Popular Disposable E-cigarette Brands— on Notice
- CTP Announces Its First Senior Advisor for Health Equity
- FDA Denies Marketing of 250+ Flavored and Tobacco-Flavored E-Liquids
- PATH Study Data User Workshop: Apply Now for the August 2023 Event
- FDA Issues Marketing Denial Orders for Approximately 6,500 Flavored E-cigarette Products
- CTPConnect Newsletter: Tobacco Product Application Resources
April
March
- CTPConnect Newsletter: CTP Responds to the Reagan-Udall Foundation Evaluation Report
- FDA Publishes Tobacco Products-Related Citizen Petitions Webpage
- FDA Updates Regulatory Documents to Include “Non-Tobacco Nicotine” Products
- FDA Denies Marketing of Two Vuse Solo Menthol E-Cigarette Products
- FDA Authorizes Copenhagen Classic Snuff to be Marketed as a Modified Risk Tobacco Product
- FDA Makes Determinations On More Than 99% of the 26 Million Tobacco Products For Which Applications Were Submitted
- FDA Proposes New Requirements for Tobacco Product Manufacturing Practices
- Event – Public Oral Hearing: FDA’s Proposed New Requirements for Tobacco Product Manufacturing Practices
February
- CTPConnect Newsletter: Advancing Health Equity in Tobacco Product Regulation
- An All-Center Approach: CTP’s Response to the Reagan-Udall Foundation Evaluation Report
- FDA Files Civil Money Penalty Complaints Against Four E-Cigarette Product Manufacturers
- CTP Announces Its Next Director of Office of Science
January
- Looking Back, Looking Ahead: FDA’s Progress on Tobacco Product Regulation in 2022
- FDA Authorizes Three New Heated Tobacco Products
- FDA Denies Marketing of Two Vuse Menthol E-Cigarette Products Following Determination They Do Not Meet Public Health Standard
- CTPConnect Newsletter: Help Teens Avoid Nicotine in the New Year
- FDA Releases New Ads, including First Focused on Mental Health Effects of Cigarette Smoking among Youth
December
- Spotlight on Science: Data from the NYTS 2022
- FDA Provides Update on External Evaluation to Strengthen Agency’s Tobacco Program
November
- FDA Warns Firms for Selling Illegal E-cigarettes That Look Like Toys, Food, and Cartoon Characters
- CDC and FDA Release NYTS Findings on Youth Use of All Tobacco Products
October
- FDA Denies Marketing of Logic’s Menthol E-Cigarette Products
- FDA, DOJ Seek Permanent Injunctions Against Six E-cigarette Manufacturers
- FDA Completes Initial Review of 95% of Non-Tobacco Nicotine Product Applications; Agency has Issued Over 60 Warning Letters to Manufacturers, Including for Products with a Submitted Application and Negative Action
- New Data Show More Than 2.5 Million U.S. Youth Currently Use E-Cigarettes
September
- FDA Seeks Nominations for Tobacco Products Scientific Advisory Committee
- CTPConnect Newsletter: Interview with New CTP Director Brian King
August
- CTP Updates “Grandfathered Tobacco Product” Term to “Pre-Existing Tobacco Product”
- Guidance: Principles for Designing and Conducting Tobacco Product Perception and Intention Studies
- FDA Warns Manufacturer for Marketing Illegal Flavored Nicotine Gummies
- CTPConnect Newsletter: FDA’s Recent Regulatory Actions on Tobacco Products
- Comment Period Closed for FDA Proposed Rules Prohibiting Menthol Cigarettes and Flavored Cigars
- Perspective: Update on FDA Review and Enforcement of Non-Tobacco Nicotine Products
July
June
- CTP Statement: June 24, 2022
- FDA Denies Authorization to Market JUUL Products
- FDA Announces Plans for Proposed Rule to Reduce Addictiveness of Cigarettes and Other Combusted Tobacco Products
- Spotlight on Science: FDA Proposes Rules Prohibiting Menthol Cigarettes and Flavored Cigars
- FDA Issues Marketing Decisions on NJOY Daily E-Cigarette Products
- FDA Launches Campaign Aimed at Preventing E-Cigarette Use Among American Indian/Alaska Native Youth
- CTPConnect Newsletter: Catch Up on Recent FDA Tobacco News
- Event - Listening Sessions: FDA’s Recently Proposed Tobacco Product Standards
May
- FDA Issues Marketing Decisions on Vuse Vibe and Vuse Ciro E-Cigarette Products
- Reminder: Electronic Submission of Premarket Applications for Non-Tobacco Nicotine Products due May 14
April
- FDA Proposes Rules Prohibiting Menthol Cigarettes and Flavored Cigars to Prevent Youth Initiation, Significantly Reduce Tobacco-Related Disease and Death
- FDA Issues Marketing Decisions on NJOY Ace E-Cigarette Products
- CTPConnect Newsletter: SE & PMTA Submission Forms, Non-Tobacco Nicotine, & More
- Mitch Zeller Reflects on Experiences as Director of FDA Center for Tobacco Products
- Requirements for Products Made with Non-Tobacco Nicotine Take Effect April 14
- FDA Issues Marketing Denial Orders to Fontem US for myblu Products
March
- New Law Clarifies FDA Authority to Regulate Synthetic Nicotine
- FDA Issues Decisions on Additional E-Cigarette Products
- Spotlight on Science: New Studies and Report Available
- FDA Authorizes Reduced Exposure Claim for IQOS 3 System Holder and Charger
- Newly Released: 2021 NYTS Findings on Youth Use of All Tobacco Products
- CTP Statement on National Academies Report on Premium Cigars Health Effects
February
January
December
- FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them
- Final Guidance: Tobacco Product User Fees: Responses to FAQs
- Adjustment of Civil Monetary Penalties for Inflation and the Annual Civil Monetary Penalties Inflation Adjustment for 2021
October
- CTPConnect Newsletter: FDA Permits Marketing of First E-Cigarette Products
- Spotlight on Science Newsletter: NYTS 2021 Released
- FDA Permits Marketing of New Oral Tobacco Products through Premarket Tobacco Product Application Pathway
- FDA Permits Marketing of E-Cigarette Products, Marking First Authorization of Its Kind by the Agency
- FDA In Brief: FDA Warns Firms for Continuing to Market E-cigarette Products After Agency Denied Authorizations
- FDA Finalizes Two Foundational Rules for Companies Seeking to Market New Tobacco Products
September
- Youth E-cigarette Use Remains a Serious Public Health Concern Amid COVID-19 Pandemic
- CTPConnect Newsletter: CTP Director Zeller’s Premarket Tobacco Review Update
- FDA Makes Significant Progress in Science-Based Public Health Application Review, Taking Action on Over 90% of More Than 6.5 Million ‘Deemed’ New Tobacco Products Submitted
August
- FDA Issues Marketing Denials to Over 55,000 Flavored ENDS
- CTPConnect Newsletter: Health Effects of Tobacco Use
- FDA Issues Refuse to File Letter to JD Nova Group LLC
July
- FDA In Brief: FDA Warns Firm With Over 15 Million Products Listed With FDA to Remove Unauthorized E-Cigarette Products from Market
- Spotlight on Science Newsletter
June
- Statement on Withdrawal of the Unified Agenda Entry Pertaining to the Advance Notice of Proposed Rulemaking for Premium Cigars and Related Request for Information
- Event - Deemed Product Review: A Conversation with the Center for Tobacco Products Office of Science
May
- Q&A with CTP's Director of Office of Regulations
- Update on FDA’s Application Review: PMTA List Posted, Progress Metrics Updated
- Spotlight on Science Newsletter
- CTPConnect Newsletter
April
March
February
- CTPConnect Newsletter
- Perspective: FDA’s Progress on Review of Tobacco Product Applications Submitted by the Sept. 9, 2020 Deadline
January
- Spotlight on Science Newsletter
- FDA Marks Historic Public Health Milestone with Finalization of Two Key Rules for Companies Seeking to Market New Tobacco Products
- FDA Warns Firms to Remove Unauthorized E-liquid Products from Market in First Letters Issued to Manufacturers that Did Not Submit Premarket Applications by Deadline
- CBP, FDA Seize Counterfeit, Unauthorized E-Cigarettes
- FDA In Brief: FDA Continues to Collaborate with Scholastic; Launches Student Magazine and Art Contest Encouraging Middle and High School Students Not to Vape
Search for past news and events in the FDA Center for Tobacco Products web archive.
Additional Resources
Sub-Topic Paragraphs
Paragraph Header
Contact CTP
Paragraph Header
Contact CTP
Contact Point
Center for Tobacco Products
Food and Drug Administration
Document Control Center
10903 New Hampshire Avenue
Building 71, Room G335
Silver Spring, MD 20993-0002
Food and Drug Administration
Document Control Center
10903 New Hampshire Avenue
Building 71, Room G335
Silver Spring, MD 20993-0002
1-877-CTP-1373 (1-877-287-1373)
(9 a.m. - 4 p.m. Eastern)
Center for Tobacco Products